MassMutual Private Wealth & Trust’s CG Oncology CGON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24
Closed -$1.62K 2416
2026
Q1
$1.62K Buy
+24
New +$1.36K ﹤0.01% 2021

Other funds holding CGON

MassMutual Private Wealth & Trust's CGON Position: Q2 2026 in Review

MassMutual Private Wealth & Trust sold out of CG Oncology (CGON) in Q2 2026, closing a stake of 24 shares — an estimated $1.62K sold.

MassMutual Private Wealth & Trust first reported a position in CGON in Q1 2026 and held it in 1 quarter. The position peaked at $1.62K in Q1 2026. 56 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • MassMutual Private Wealth & Trust reported no remaining CG Oncology position as of Q2 2026 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 24 CG Oncology shares in Q2 2026, an estimated $1.62K.
  • MassMutual Private Wealth & Trust first reported a position in CG Oncology in Q1 2026 and held it in 1 quarter.
  • MassMutual Private Wealth & Trust's CG Oncology position peaked at $1.62K in Q1 2026.
  • 56 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.